Showing results (361-370 of 2,397) with videos related to

Sort By:
Pageof 240
Translational Lung Cancer Research|January 9, 2026
Real-world outcomes of first-line immunotherapy and subsequent systemic therapies in pleural mesothelioma: a multicenter study in ChinaBinhe Tian, Boyu Sun, Zixiang Zhou, et al.
Translational Lung Cancer Research|January 9, 2026
Clinical characteristics of post-operative N2 nodal upstaging in non-small cell lung cancer: a retrospective cohort studySun Young Choi, Myung Jin Song, Byung Soo Kwon, et al.
Translational Lung Cancer Research|January 9, 2026
Completion lobectomy following segmentectomy for malignant lung tumors: a multi-institutional study of surgical feasibility, oncologic outcomes, and diagnostic challenges (ESSG-02 study)Takuya Watanabe, Kosuke Fujino, Tadashi Sakane, et al.
Translational Lung Cancer Research|January 9, 2026
Patient-reported outcomes of radiofrequency ablation-video-assisted thoracoscopic surgery (VATS) hybrid surgery vs. uniportal VATS for multiple primary lung nodules: a longitudinal cohort studyRuifeng Xu, Guochao Zhang, Na Ren, et al.
Translational Lung Cancer Research|January 9, 2026
A study protocol of a single-arm, prospective, open-label, non-controlled, phase II study of neoadjuvant BL-B01D1 combined with aumolertinib in resectable stage II-IIIB non-small cell lung cancer patients with EGFR mutationYue Chen, Jiandong Mei, Ge Gao, et al.
Translational Lung Cancer Research|October 24, 2025
Multidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC): 2nd Spanish Lung Cancer Group (GECP) expert consensus statementAylen Vanessa Ospina-Serrano, Jose Luis González-Larriba, Ernest Nadal, et al.
Translational Lung Cancer Research|October 24, 2025
The evolving role of wedge resection in early-stage non-small cell lung cancer: a literature reviewIlaria Ceccarelli, Marion Durand, Agathe Seguin-Givelet
Translational Lung Cancer Research|October 24, 2025
Pre-screening value of serum albumin and the glucose-lymphocyte ratio as the "transport-activation" effectors of immune checkpoint inhibitors in small cell lung cancerChenxi Wang, Jinhe Xu, Ying Chen, et al.
Translational Lung Cancer Research|October 24, 2025
Real-world outcomes and association between immune-related adverse events and therapeutic efficacy of nivolumab plus ipilimumab in elderly patients (≥75 years) with advanced non-small cell lung cancerSoichiro Minami, Tsuyoshi Doman, Yukihiro Toi, et al.
Translational Lung Cancer Research|October 24, 2025
Potential efficacy of anti-angiogenic therapy combined with immunotherapy for advanced SMARCA4-deficient thoracic tumor: a retrospective studyBeibei Liu, Danni Wang, Yujing Li, et al.
Pageof 240